{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:48:44Z","timestamp":1792180124174,"version":"4.4.0"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023864","name":"NHS Innovation Accelerator","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG067015"],"award-info":[{"award-number":["R01AG067015"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S011625\/1"],"award-info":[{"award-number":["MR\/S011625\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.nbd.2023.106337","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T22:45:04Z","timestamp":1698792304000},"page":"106337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Elucidating distinct molecular signatures of Lewy body dementias"],"prefix":"10.1016","volume":"188","author":[{"given":"Joshua","family":"Harvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Pishva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Chouliaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Lunnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2023.106337_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2006-9309","article-title":"Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders","volume":"9","author":"Abdi","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2023.106337_bb0015","article-title":"Selective vulnerability in \u03b1-synucleinopathies","volume":"1\u201324","author":"Alegre-Abarrategui","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2023.106337_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-020-00954-8","article-title":"Neuroinflammation in dementia with Lewy bodies: a human post-mortem study","volume":"10","author":"Amin","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106337_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","article-title":"Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-Centre study","volume":"141","author":"Attems","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2023.106337_bb0030","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106337_bb0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00412-004-0281-9","article-title":"The enhancement of histone H4 and H2A serine 1 phosphorylation during mitosis and S-phase is evolutionarily conserved","volume":"112","author":"Barber","year":"2004","journal-title":"Chromosoma"},{"key":"10.1016\/j.nbd.2023.106337_bb0040","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jalz.2016.04.005","article-title":"Synaptic proteins predict cognitive decline in Alzheimer\u2019s disease and Lewy body dementia","volume":"12","author":"Bereczki","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2023.106337_bb0045","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/brain\/awx352","article-title":"Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach","volume":"141","author":"Bereczki","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2023.106337_bb0050","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/jnnp-2013-307228","article-title":"Apolipoprotein E \u03b52 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort","volume":"85","author":"Berge","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106337_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10048-008-0124-6","article-title":"Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease","volume":"9","author":"Beyer","year":"2008","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nbd.2023.106337_bb0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12017-011-8163-9","article-title":"Next-generation sequencing reveals regional differences of the \u03b1-Synuclein methylation state independent of Lewy body disease","volume":"13","author":"de Boni","year":"2011","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.nbd.2023.106337_bb0065","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023630","article-title":"Potential pathways of abnormal tau and \u03b1-Synuclein dissemination in sporadic Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"8","author":"Braak","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.nbd.2023.106337_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.nbd.2023.106337_bb0075","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies","volume":"23","author":"Bras","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2023.106337_bb0085","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.neurobiolaging.2014.02.009","article-title":"Differential aggregation properties of alpha-synuclein isoforms","volume":"35","author":"Bungeroth","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2023.106337_bb0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.2005.081711","article-title":"Motor subtype and cognitive decline in Parkinson\u2019s disease, Parkinson\u2019s disease with dementia, and dementia with Lewy bodies","volume":"77","author":"Burn","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106337_bb0095","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"issue":"9440","key":"10.1016\/j.nbd.2023.106337_bib799","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"\u03b1-Synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2023.106337_bib815","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajhg.2011.08.009","article-title":"Translation initiator EIF4G1 mutations in familial Parkinson disease","volume":"89","author":"Chartier-Harlin","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"53","key":"10.1016\/j.nbd.2023.106337_bb0105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"533","author":"Chia","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2023.106337_bb0110","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/hmg\/dds470","article-title":"MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein","volume":"22","author":"Cho","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2023.106337_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101822","article-title":"Epigenetic regulation in the pathophysiology of Lewy body dementia","volume":"192","author":"Chouliaras","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106337_bb0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JPD-181549","article-title":"Longitudinal epigenome-wide methylation study of cognitive decline and motor progression in Parkinson\u2019s disease","volume":"9","author":"Chuang","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.nbd.2023.106337_bib808","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archneurol.2009.54","article-title":"Association of glucocerebrosidase mutations with dementia with lewy bodies","volume":"66","author":"Clark","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bib818","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fpsyt.2016.00089","article-title":"The genetic basis of cognitive impairment and dementia in Parkinson\u2019s disease","volume":"7","author":"Collins","year":"2016","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.nbd.2023.106337_bb0125","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1093\/brain\/aws211","article-title":"Neuropathological correlates of dopaminergic imaging in Alzheimer\u2019s disease and Lewy body dementias","volume":"135","author":"Colloby","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2023.106337_bb0130","first-page":"216","article-title":"Regional overlap of pathologies in Lewy body disorders","volume":"76","author":"Colom-Cadena","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2023.106337_bib805","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajmg.b.32549","article-title":"Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson\u2019s disease and lewy body dementias: review and meta-analyses","volume":"177","author":"Creese","year":"2018","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.nbd.2023.106337_bb0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13041-017-0316-9","article-title":"An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias","volume":"10","author":"Datta","year":"2017","journal-title":"Mol. Brain"},{"issue":"2","key":"10.1016\/j.nbd.2023.106337_bib829","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.parkreldis.2012.09.013","article-title":"Analysis of the C9orf72 repeat in parkinson\u2019s disease, essential tremor and restless legs syndrome","volume":"19","author":"Dejesus-Hernandez","year":"2013","journal-title":"Parkinsonism & related disorders"},{"key":"10.1016\/j.nbd.2023.106337_bb0140","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.14336\/AD.2019.0225","article-title":"AmpliSeq transcriptome of laser captured neurons from Alzheimer brain: comparison of single cell versus neuron pools","volume":"10","author":"Deng","year":"2019","journal-title":"Aging Dis."},{"key":"10.1016\/j.nbd.2023.106337_bb0145","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1074\/jbc.C110.212589","article-title":"Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases","volume":"286","author":"Desplats","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2023.106337_bb0155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/mds.27403","article-title":"Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies","volume":"33","author":"Donaghy","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0160","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jagp.2022.02.003","article-title":"Blood mRNA expression in Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"30","author":"Donaghy","year":"2022","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106337_bb0165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","article-title":"Concomitant pathologies among a spectrum of parkinsonian disorders","volume":"20","author":"Dugger","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.nbd.2023.106337_bib822","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","article-title":"Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease","volume":"74","author":"Edwards","year":"2010","journal-title":"Ann. Human Genet."},{"key":"10.1016\/j.nbd.2023.106337_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13072-017-0130-8","article-title":"DNA methylation and DNA methyltransferases","volume":"10","author":"Edwards","year":"2017","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.nbd.2023.106337_bb0175","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/nar\/10.8.2709","article-title":"Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells","volume":"10","author":"Ehrlich","year":"1982","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2023.106337_bb0180","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/mds.27333","article-title":"Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies","volume":"33","author":"Erskine","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac125","article-title":"Genome-wide association studies for Alzheimer\u2019s disease: bigger is not always better","volume":"4","author":"Escott-Price","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2023.106337_bb0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with parkinsonism and\u00a0?-synuclein genomic multiplications","volume":"55","author":"Farrer","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0195","series-title":"Cross-platform Transcriptional Profiling Identifies Common and Distinct Molecular Pathologies in Lewy Body Diseases","author":"Feleke","year":"2021"},{"key":"10.1016\/j.nbd.2023.106337_bb0200","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1101\/gr.119867.110","article-title":"A DNA methylation fingerprint of 1628 human samples","volume":"22","author":"Fernandez","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.nbd.2023.106337_bb0205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ana.24384","article-title":"MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder","volume":"77","author":"Fern\u00e1ndez-Santiago","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/genes9020063","article-title":"Alternative splicing of alpha- and Beta-Synuclein genes plays differential roles in Synucleinopathies","volume":"9","author":"G\u00e1mez-Valero","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.nbd.2023.106337_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49668-y","article-title":"Comprehensive proteomic profiling of plasma-derived extracellular vesicles from dementia with Lewy bodies patients","volume":"9","author":"G\u00e1mez-Valero","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2023.106337_bb0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neulet.2013.10.045","article-title":"Association of a polymorphism in mitochondrial transcription factor a (TFAM) with Parkinson\u2019s disease dementia but not dementia with Lewy bodies","volume":"557","author":"Gatt","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2023.106337_bb0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2016.05.060","article-title":"Histone H3 acetylation in the postmortem Parkinson\u2019s disease primary motor cortex","volume":"627","author":"Gebremedhin","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2023.106337_bb0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2016.06.004","article-title":"Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies","volume":"94","author":"Geiger","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106337_bb0235","article-title":"Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies","volume":"51","author":"Gibbons","year":"2022","journal-title":"medRxiv"},{"issue":"9","key":"10.1016\/j.nbd.2023.106337_bib812","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamaneurol.2013.488","article-title":"Next-generation phenotyping using the Parkin example","volume":"70","author":"Gr\u00fcnewald","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0240","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/ana.24664","article-title":"\u03b1-Synuclein genetic variability: a biomarker for dementia in Parkinson disease","volume":"79","author":"Guella","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2015.10.028","article-title":"Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"38","author":"Guerreiro","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2023.106337_bb0250","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0255","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nbd.2019.04.004","article-title":"Heritability and genetic variance of dementia with Lewy bodies","volume":"127","author":"Guerreiro","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106337_bb0260","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/15476286.2015.1063770","article-title":"Long non-coding RNA and chromatin remodeling","volume":"12","author":"Han","year":"2015","journal-title":"RNA Biol."},{"key":"10.1016\/j.nbd.2023.106337_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.40.1.1","article-title":"The Lewy body variant of Alzheimer\u2019s disease","volume":"40","author":"Hansen","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106337_bb0270","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2017.12.037","article-title":"Pathological histone acetylation in Parkinson\u2019s disease: neuroprotection and inhibition of microglial activation through SIRT 2 inhibition","volume":"666","author":"Harrison","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.nbd.2023.106337_bib809","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-Control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bib811","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.parkreldis.2016.07.015","article-title":"LRRK2 variation and dementia with lewy bodies","volume":"31","author":"Heckman","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0275","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.20324","article-title":"Sydney multicenter study of Parkinson\u2019s disease: non-L-dopa-responsive problems dominate at 15 years","volume":"20","author":"Hely","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0280","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000075","article-title":"Next-generation profiling to identify the molecular etiology of Parkinson dementia","volume":"2","author":"Henderson-Smith","year":"2016","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.nbd.2023.106337_bb0285","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1017\/cjn.2016.2","article-title":"The prevalence and incidence of dementia with lewy bodies: a systematic review","volume":"43","author":"Hogan","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2023.106337_bb0290","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnagi.2016.00036","article-title":"microRNA profiles in Parkinson\u2019s disease prefrontal cortex","volume":"8","author":"Hoss","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2023.106337_bb0295","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bpa.12182","article-title":"Regional multiple pathology scores are associated with cognitive decline in Lewy body dementias","volume":"25","author":"Howlett","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2023.106337_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","article-title":"Single-cell RNA sequencing technologies and bioinformatics pipelines","volume":"50","author":"Hwang","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"9440","key":"10.1016\/j.nbd.2023.106337_bib801","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between \u03b1-Synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Ib\u00e1\u00f1ez","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2023.106337_bib827","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fnins.2018.00230","article-title":"Pleiotropic effects of variants in dementia genes in Parkinson Disease","volume":"12","author":"Ibanez","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2023.106337_bb0305","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archneur.65.4.514","article-title":"Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia","volume":"65","author":"Ikeuchi","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0310","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0315","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2023.106337_bb0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/genes8060148","article-title":"CpG and non-CpG methylation in epigenetic gene regulation and brain function","volume":"8","author":"Jang","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.nbd.2023.106337_bb0330","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000197890","article-title":"Significance of brain lesions in Parkinson disease dementia and lewy body dementia","volume":"24","author":"Jellinger","year":"2009","journal-title":"Dement. Clin. Pract."},{"key":"10.1016\/j.nbd.2023.106337_bb0335","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","article-title":"Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies","volume":"125","author":"Jellinger","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2023.106337_bb0340","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","article-title":"Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease?","volume":"16","author":"Jellinger","year":"2018","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.nbd.2023.106337_bib802","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1212\/01.WNL.0000133401.09043.44","article-title":"SNCA multiplication is not a common cause of Parkinson disease or dementia with lewy bodies","volume":"63","author":"Johnson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106337_bb0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","article-title":"Clinical prevalence of Lewy body dementia","volume":"10","author":"Kane","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2023.106337_bb0350","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10048-011-0308-3","article-title":"Genome-scale methylation analysis of Parkinson\u2019s disease patients\u2019 brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1","volume":"13","author":"Kaut","year":"2012","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nbd.2023.106337_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/life12040502","article-title":"Epigenome-wide analysis of DNA methylation in Parkinson\u2019s disease cortex","volume":"12","author":"Kaut","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.nbd.2023.106337_bb0360","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/brain\/awq059","article-title":"Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study","volume":"133","author":"Kempster","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2023.106337_bb0365","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.220","article-title":"Exome sequencing in dementia with Lewy bodies","volume":"6","author":"Keogh","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106337_bb0370","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2023.106337_bb0375","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nsmb.2372","article-title":"5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary","volume":"19","author":"Khare","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.nbd.2023.106337_bb0380","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40478-016-0334-3","article-title":"Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations","volume":"4","author":"Khundakar","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2023.106337_bb0385","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainresbull.2009.06.018","article-title":"Neuropathology of Lewy body disorders","volume":"80","author":"K\u00f6vari","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2023.106337_bib831","doi-asserted-by":"crossref","first-page":"214.e13","DOI":"10.1016\/j.neurobiolaging.2016.08.023","article-title":"Analysis of C9orf72 repeat expansions in a large international cohort of dementia with lewy bodies","volume":"49","author":"Kun-Rodrigues","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"223","key":"10.1016\/j.nbd.2023.106337_bb0390","first-page":"e1","article-title":"A comprehensive screening of copy number variability in dementia with Lewy bodies","volume":"75","author":"Kun-Rodrigues","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.nbd.2023.106337_bib819","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0891988709332945","article-title":"APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study","volume":"22","author":"Kurz","year":"2009","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00439-016-1749-4","article-title":"Copy number variability in Parkinson\u2019s disease: assembling the puzzle through a systems biology approach","volume":"136","author":"La Cognata","year":"2017","journal-title":"Hum. Genet."},{"issue":"19","key":"10.1016\/j.nbd.2023.106337_bib825","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0000000000001946","article-title":"Role for the microtubule-associated protein Tau variant p.A152T in risk of \u03b1-Synucleinopathies","volume":"85","author":"Labb\u00e9","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106337_bib826","first-page":"1297","article-title":"MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies. Alzheimers","volume":"12","author":"Labb\u00e9","year":"2016","journal-title":"Dement"},{"key":"10.1016\/j.nbd.2023.106337_bb0400","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.expneurol.2012.01.024","article-title":"iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson\u2019s disease dementia","volume":"234","author":"Lehnert","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0405","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archneur.63.3.370","article-title":"Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype","volume":"63","author":"Leverenz","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0410","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13059-020-01960-1","article-title":"Hemispheric asymmetry in the human brain and in Parkinson\u2019s disease is linked to divergent epigenetic patterns in neurons","volume":"21","author":"Li","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.nbd.2023.106337_bb0415","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Lewy bodies contain altered \u03b1-Synuclein in brains of many familial Alzheimer\u2019s disease patients with mutations in Presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2023.106337_bb0420","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"issue":"53","key":"10.1016\/j.nbd.2023.106337_bb0425","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41588-021-00847-6","article-title":"Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson\u2019s disease","volume":"536","author":"Liu","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2023.106337_bb0430","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neulet.2008.02.041","article-title":"A pilot study for circadian gene disturbance in dementia patients","volume":"435","author":"Liu","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.nbd.2023.106337_bib803","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1385\/JMN:24:3:337","article-title":"Multiplication of the \u03b1-Synuclein gene is not a common disease mechanism in lewy body disease","volume":"24","author":"Lockhart","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2023.106337_bb0435","doi-asserted-by":"crossref","first-page":"5012129","DOI":"10.1155\/2017\/5012129","article-title":"The contribution of \u03b1-Synuclein spreading to Parkinson\u2019s disease Synaptopathy","volume":"2017","author":"Longhena","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/j.nbd.2023.106337_bb0440","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-0327(99)00123-8","article-title":"Depression in the carers of dementia sufferers: a comparison of the carers of patients suffering from dementia with Lewy bodies and the carers of patients with Alzheimer\u2019s disease","volume":"59","author":"Lowery","year":"2000","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0445","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nn.3782","article-title":"Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease","volume":"17","author":"Lunnon","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2023.106337_bb0450","article-title":"Variation in 5-hydroxymethylcytosine across human cortex and cerebellum","volume":"17","author":"Lunnon","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.nbd.2023.106337_bb0455","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.aan3351","article-title":"Single-cell methylomes identify neuronal subtypes and regulatory elements in mammalian cortex","volume":"357","author":"Luo","year":"2017","journal-title":"Science (80)"},{"key":"10.1016\/j.nbd.2023.106337_bb0460","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1095001","article-title":"TAF1 activates transcription by phosphorylation of serine 33 in histone H2B","volume":"304","author":"Maile","year":"2004","journal-title":"Science (80)"},{"key":"10.1016\/j.nbd.2023.106337_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098657","article-title":"The chaperone-like activity of \u03b1-Synuclein attenuates aggregation of its alternatively spliced isoform, 112-Synuclein in vitro: plausible cross-talk between isoforms in protein aggregation","volume":"9","author":"Manda","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2023.106337_bb0470","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/NEN.0b013e3181ac10a7","article-title":"Lewy body pathology in Normal elderly subjects","volume":"68","author":"Markesbery","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0475","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41593-020-0690-y","article-title":"Epigenomic analysis of Parkinson\u2019s disease neurons identifies Tet2 loss as neuroprotective","volume":"23","author":"Marshall","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2023.106337_bb0480","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-publhealth-040617-014629","article-title":"Environmental influences on the epigenome: exposure- associated DNA methylation in human populations","volume":"39","author":"Martin","year":"2018","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.nbd.2023.106337_bb0485","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.26542","article-title":"Neocortical Lewy body pathology parallels Parkinson\u2019s dementia, but not always","volume":"93","author":"Martin","year":"2023","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.nbd.2023.106337_bib796","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA neurology"},{"key":"10.1016\/j.nbd.2023.106337_bb0490","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106337_bb0500","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07107","article-title":"Genome-scale DNA methylation maps of pluripotent and differentiated cells","volume":"454","author":"Meissner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2023.106337_bib820","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.parkreldis.2016.04.013","article-title":"Apolipoprotein E \u03954 does not affect cognitive performance in patients with Parkinson\u2019s disease","volume":"29","author":"Mengel","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0505","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00439-017-1807-6","article-title":"Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions","volume":"136","author":"Morriss","year":"2017","journal-title":"Hum. Genet."},{"issue":"4","key":"10.1016\/j.nbd.2023.106337_bib821","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.24946","article-title":"Genetic influences on cognitive decline in Parkinson\u2019s disease","volume":"27","author":"Morley","year":"2012","journal-title":"Mov. Disord. Offi. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nbd.2023.106337_bb0510","first-page":"143","article-title":"Hospitalization in people with dementia with Lewy bodies: frequency, duration, and cost implications","volume":"10","author":"Mueller","year":"2018","journal-title":"Alzheimer\u2019s Dement. Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.nbd.2023.106337_bb0515","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2019.01.005","article-title":"Survival time and differences between dementia with Lewy bodies and Alzheimer\u2019s disease following diagnosis: a meta-analysis of longitudinal studies","volume":"50","author":"Mueller","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.nbd.2023.106337_bb0520","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of \u03b1-Synuclein Carboxy-terminus on fibril formation in vitro \u2020","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.nbd.2023.106337_bb0525","first-page":"1","article-title":"Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders","volume":"221","author":"Nabais","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.nbd.2023.106337_bb0530","article-title":"Differential blood DNA methylation across Lewy body dementias","volume":"13","author":"Nasamran","year":"2021","journal-title":"Alzheimer\u2019s Dement. Diagnosis, Assess. Dis. Monit."},{"issue":"Pt 7","key":"10.1016\/j.nbd.2023.106337_bib806","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain\u00a0 J. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0535","doi-asserted-by":"crossref","first-page":"e1916439","DOI":"10.1001\/jamanetworkopen.2019.16439","article-title":"Association of Longitudinal \u03b2-amyloid accumulation determined by positron emission tomography with clinical and cognitive decline in adults with probable Lewy body dementia","volume":"2","author":"Nedelska","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.nbd.2023.106337_bb0540","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.brainres.2017.11.009","article-title":"MicroRNA expression patterns in human anterior cingulate and motor cortex: a study of dementia with Lewy bodies cases and controls","volume":"1678","author":"Nelson","year":"2018","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.nbd.2023.106337_bib800","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20753","article-title":"Clinical heterogeneity of \u03b1-Synuclein gene duplication in Parkinson\u2019s disease","volume":"59","author":"Nishioka","year":"2006","journal-title":"Ann. Neurol."},{"issue":"Pt 10","key":"10.1016\/j.nbd.2023.106337_bib823","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/brain\/awu201","article-title":"Genetic impact on cognition and brain function in newly diagnosed Parkinson\u2019s disease: ICICLE-PD Study","volume":"137","author":"Nombela","year":"2014","journal-title":"Brain\u00a0 J. Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0545","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JPD-171092","article-title":"Glucocerebrosidase mutations in Parkinson disease","volume":"7","author":"O\u2019Regan","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2023.106337_bb0550","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11910-018-0874-y","article-title":"The genetics of dementia with Lewy bodies: current understanding and future directions","volume":"18","author":"Orme","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.nbd.2023.106337_bb0555","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-020-0879-z","article-title":"Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies","volume":"8","author":"Orme","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2023.106337_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9497147","article-title":"Meta-analysis of the relationship between the APOE gene and the onset of Parkinson\u2019s disease dementia","volume":"2018","author":"Pang","year":"2018","journal-title":"Parkinsons. Dis."},{"key":"10.1016\/j.nbd.2023.106337_bb0565","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1789.2005.00644.x","article-title":"Widespread and abundant \u03b1-synuclein pathology in a neurologically unimpaired subject","volume":"25","author":"Parkkinen","year":"2005","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2023.106337_bb0570","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/10409238.2013.844092","article-title":"Gene regulation by noncoding RNAs","volume":"49","author":"Patil","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.nbd.2023.106337_bb0575","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2017.4206","article-title":"Association of Polygenic Risk Score with Cognitive Decline and Motor Progression in Parkinson disease","volume":"75","author":"Paul","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0580","doi-asserted-by":"crossref","first-page":"208","DOI":"10.14336\/AD.2017.0505","article-title":"Glucocerebrosidase mRNA is diminished in brain of Lewy body diseases and changes with disease progression in blood","volume":"9","author":"Perez-Roca","year":"2018","journal-title":"Aging Dis."},{"key":"10.1016\/j.nbd.2023.106337_bb0585","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.bbrc.2016.09.114","article-title":"Gene expression profiling of brain samples from patients with Lewy body dementia","volume":"479","author":"Pietrzak","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.nbd.2023.106337_bb0590","first-page":"1","article-title":"Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology","volume":"131","author":"Pihlstr\u00f8m","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.nbd.2023.106337_bib797","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.parkreldis.2009.06.007","article-title":"A swedish family with de Novo Alpha-Synuclein A53T mutation: evidence for early cortical dysfunction","volume":"15","author":"Puschmann","year":"2009","journal-title":"Parkinsonism & related disorders"},{"key":"10.1016\/j.nbd.2023.106337_bb0595","first-page":"1","article-title":"Clinical effects of Lewy body pathology in cognitively impaired individuals","volume":"2023","author":"Quadalti","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2023.106337_bb0600","article-title":"Postmortem cortical transcriptomics of Lewy body dementia reveal mitochondrial dysfunction and lack of Neuroinflammation","author":"Rajkumar","year":"2019","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106337_bb0605","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.archger.2008.10.001","article-title":"Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer\u2019s disease (AD)","volume":"49","author":"Ricci","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.nbd.2023.106337_bb0610","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","article-title":"Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis","volume":"89","author":"Rizzo","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106337_bb0615","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaw1219","article-title":"Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution","volume":"363","author":"Rodriques","year":"2019","journal-title":"Science (80)"},{"key":"10.1016\/j.nbd.2023.106337_bb0620","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1038\/s41598-019-43458-2","article-title":"GBA and APOE \u03b54 associate with sporadic dementia with Lewy bodies in European genome wide association study","volume":"9","author":"Rongve","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2023.106337_bb0625","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2020.06.023","article-title":"An epigenome-wide association study of Alzheimer\u2019s disease blood highlights robust DNA hypermethylation in the HOXB6 gene","volume":"95","author":"Roubroeks","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2023.106337_bb0630","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrn.2017.90","article-title":"Noncoding RNAs in neurodegeneration","volume":"18","author":"Salta","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2023.106337_bb0635","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.214","article-title":"Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns","volume":"6","author":"Sanchez-Mut","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106337_bb0640","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01080","article-title":"Active genes are tri-methylated at K4 of histone H3","volume":"419","author":"Santos-Rosa","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2023.106337_bb0645","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bpa.12511","article-title":"Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies","volume":"28","author":"Santpere","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2023.106337_bb0650","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1101\/gad.300704","article-title":"A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin","volume":"18","author":"Schotta","year":"2004","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.nbd.2023.106337_bib828","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/ejhg.2014.300","article-title":"Rare Variants in \u03b2-Amyloid Precursor Protein (APP) and Parkinson\u2019s Disease","volume":"23","author":"Schulte","year":"2015","journal-title":"Eur. J. Human Genet."},{"issue":"3","key":"10.1016\/j.nbd.2023.106337_bib807","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mds.24045","article-title":"Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson\u2019s disease course","volume":"27","author":"Set\u00f3-Salvia","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0655","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-016-0011-3","article-title":"An overview of genome-wide association studies in Alzheimer\u2019s disease","volume":"32","author":"Shen","year":"2016","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.nbd.2023.106337_bb0660","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s42003-019-0324-7","article-title":"Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data","volume":"2","author":"Shigemizu","year":"2019","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.nbd.2023.106337_bib813","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.parkreldis.2014.08.019","article-title":"Early-onset Parkinson\u2019s disease due to PINK1 p.Q456X mutation--clinical and functional study","volume":"20","author":"Siuda","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0665","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neurobiolaging.2018.09.024","article-title":"A cross-brain regions study of ANK1 DNA methylation in different neurodegenerative diseases","volume":"74","author":"Smith","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2023.106337_bb0670","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-019-0636-y","article-title":"Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer\u2019s disease","volume":"11","author":"Smith","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.nbd.2023.106337_bb0675","first-page":"1234","article-title":"Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.nbd.2023.106337_bb0680","first-page":"1","article-title":"A meta-analysis of epigenome-wide association studies in Alzheimer\u2019s disease highlights novel differentially methylated loci across cortex","volume":"121","author":"Smith","year":"2021","journal-title":"Nat. Commun."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2023.106337_bib798","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2011.07.047","article-title":"Initial neuropsychological impairments in patients with the E46K mutation of the \u03b1-Synuclein gene (PARK 1)","volume":"310","author":"Somme","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2023.106337_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-01033-1","article-title":"Assessment of genetic risk for improved clinical-neuropathological correlations","volume":"8","author":"Spencer","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"5","key":"10.1016\/j.nbd.2023.106337_bib810","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mds.26161","article-title":"Cognitive profile of LRRK2 -related Parkinson\u2019s disease","volume":"30","author":"Srivatsal","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0690","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/mds.22184","article-title":"Neuronal gene expression correlates of Parkinson\u2019s disease with dementia","volume":"23","author":"Stamper","year":"2008","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.nbd.2023.106337_bib814","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/jnnp.2006.105676","article-title":"Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations","volume":"78","author":"Steinlechner","year":"2006","journal-title":"J. Neurol.\u00a0 Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106337_bb0695","first-page":"1","article-title":"Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson\u2019s disease","volume":"3","author":"St\u00f6ger","year":"2017","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.nbd.2023.106337_bb0700","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jalz.2017.03.001","article-title":"Genetic analysis of \u03b1-synuclein 3\u2032 untranslated region and its corresponding microRNAs in relation to Parkinson\u2019s disease compared to dementia with Lewy bodies","volume":"13","author":"Tagliafierro","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2023.106337_bb0705","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.28342","article-title":"Genome-wide association studies of cognitive and motor progression in Parkinson\u2019s disease","volume":"36","author":"Tan","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106337_bb0710","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.28994","article-title":"A longitudinal study of plasma pTau181 in mild cognitive impairment with Lewy bodies and Alzheimer\u2019s disease","volume":"37","author":"Thomas","year":"2022","journal-title":"Mov. Disord."},{"issue":"16","key":"10.1016\/j.nbd.2023.106337_bb0715","first-page":"1","article-title":"Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain","volume":"161","author":"Toker","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2023.106337_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101771","article-title":"From protein biomarkers to proteomics in dementia with Lewy bodies","volume":"83","author":"Tsamourgelis","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.nbd.2023.106337_bb0725","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fgene.2019.00584","article-title":"The landscape of SNCA transcripts across synucleinopathies: new insights from long reads sequencing analysis","volume":"10","author":"Tseng","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.nbd.2023.106337_bb0730","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE \u03b54 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0740","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2018.06.017","article-title":"Methylation changes and aberrant expression of FGFR3 in Lewy body disease neurons","volume":"1697","author":"Tsuchida","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2023.106337_bb0745","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jalz.2018.02.005","article-title":"APOE DNA methylation is altered in Lewy body dementia","volume":"14","author":"Tulloch","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2023.106337_bb0750","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awad183","article-title":"Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease","author":"Tunold","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2023.106337_bb0755","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1073\/pnas.1324209111","article-title":"Splice isoform and pharmacological studies reveal that sterol depletion relocalizes \u03b1-synuclein and enhances its toxicity","volume":"111","author":"Valastyan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2023.106337_bb0760","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-020-00388-2","article-title":"Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach","volume":"15","author":"Van Steenoven","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2023.106337_bb0765","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nature02985","article-title":"Role of histone H2A ubiquitination in Polycomb silencing","volume":"431","author":"Wang","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2023.106337_bb0770","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1186\/s12864-015-2207-8","article-title":"RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles","volume":"16","author":"Webb","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.nbd.2023.106337_bb0775","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.12688\/f1000research.11725.1","article-title":"Current concepts and controversies in the pathogenesis of Parkinson\u2019s disease dementia and dementia with Lewy bodies","volume":"6","author":"Weil","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.nbd.2023.106337_bb0780","first-page":"88","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"25","author":"Weintraub","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nbd.2023.106337_bib816","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2023.106337_bb0785","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.nbd.2023.106337_bib824","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.neurobiolaging.2014.12.006","article-title":"Association between MAPT haplotype and memory function in patients with Parkinson\u2019s disease and healthy aging individuals","volume":"36","author":"Winder-Rhodes","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.nbd.2023.106337_bib817","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/brain\/aws157","article-title":"The Catechol-O-Methyltransferase Val158Met polymorphism modulates Fronto-Cortical dopamine turnover in early Parkinson\u2019s disease: A PET study","volume":"135","author":"Wu","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nbd.2023.106337_bib830","doi-asserted-by":"crossref","first-page":"1311.e3","DOI":"10.1016\/j.neurobiolaging.2012.09.002","article-title":"Screening for C9orf72 repeat expansions in parkinsonian syndromes","volume":"34","author":"Yeh","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.nbd.2023.106337_bib804","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of \u03b1-Synuclein causes Parkinson and lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann.Neurol."},{"key":"10.1016\/j.nbd.2023.106337_bb0790","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/abio.2002.5719","volume":"306","author":"Zhang","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2023.106337_bb0795","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fnmol.2018.00391","article-title":"A comprehensive analysis of the association between SNCA polymorphisms and the risk of Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2018","journal-title":"Front. Mol. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123003534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123003534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:39:38Z","timestamp":1760852378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123003534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":190,"alternative-id":["S0969996123003534"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106337","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating distinct molecular signatures of Lewy body dementias","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106337"}}